Partial Thickness Wound

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Organogenesis
OrganogenesisCANTON, MA
1 program
PuraPly™ Antimicrobial Wound MatrixN/A1 trial
Active Trials
NCT03286452CompletedEst. Jan 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OrganogenesisPuraPly™ Antimicrobial Wound Matrix

Clinical Trials (1)

NCT03286452OrganogenesisPuraPly™ Antimicrobial Wound Matrix

The RESPOND Registry

Start: Feb 2017Est. completion: Jan 2019
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space